ME Therapeutics Holdings Inc. (CSE:METX)
2.270
-0.230 (-9.20%)
At close: Feb 9, 2026
-71.63% (1Y)
| Market Cap | 68.21M +77.1% |
| Revenue (ttm) | n/a |
| Net Income | -1.25M |
| EPS | -0.04 |
| Shares Out | 30.05M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,538 |
| Average Volume | 850 |
| Open | 2.520 |
| Previous Close | 2.500 |
| Day's Range | 2.150 - 2.520 |
| 52-Week Range | 2.010 - 11.000 |
| Beta | -0.17 |
| RSI | 40.30 |
| Earnings Date | Nov 27, 2025 |